With healthcare expenses continuing to rise, the pressure has never been greater on hospitals to proactively manage costs. As a result, hospitals throughout the US are evaluating new ways to improve patient outcomes while simultaneously containing or avoiding costs.
The Economic Analysis Tool was created by Adi Renbaum of ANR Consulting and Thomas Hopkins, MD MBA (Duke University) to demonstrate a new approach to business intelligence in healthcare, providing clinicians and executives with the tools they need to simultaneously improve patient care and avoid costs. The Economic Analysis Tool can be used as part of a personalized and predictive model that can be leveraged to evaluate the cost effectiveness of purchasing noninvasive hemodynamic monitoring equipment.
The Economic Analysis Tool is product-neutral, and being such, does not take into consideration product cost.
For a more detailed analysis of how the 100% noninvasive CHEETAH NICOM and Starling SV hemodynamic systems can address your particular needs, please click on the button at the bottom of this page, and a local representative will contact you.
Cost Avoidance With Use of Advanced Hemodynamic Monitoring
The Budget Impact Analysis presented here is a simplified pro forma representation of the potential economic impact of improved fluid management. This model is based on the existing medical literature on Goal Directed Therapy and is not meant to predict actual results.
Copyright Cheetah Medical Inc. All Rights Reserved.